World Class
Global HANALL

Global
HANALL

Mission

Healthier & longer lives for patients

Trust
Reliability

Trust
Reliability

Value

We value integrity
and the highest standards for all business practices.

Explore
Innovation

Explore
Innovation

Innovation

Our Promise is to discover and develop innovative medicines to fulfill unmet medical needs.

R&D Synergy

Open collaboration with academia, biotech and pharma

2023-05-26 NEW

HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson’s Disease

In Detail
2023-05-19 NEW

HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease

In Detail
2023-04-28 NEW

HanAll Biopharma Reports First Quarter 2023 Results and Provides Business Update

In Detail